img
img
Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment      
Yazarlar (11)
Eda Yalçın
Göknur Kara
Ordu Üniversitesi, Türkiye
Dr. Öğr. Üyesi Ekin ÇELİK Dr. Öğr. Üyesi Ekin ÇELİK
Kırşehir Ahi Evran Üniversitesi, Türkiye
Ferda Pınarlı
Guleser Saylam
Ceren Sucularlı
Hacettepe Üniversitesi, Türkiye
Serhat Ozturk
Esın Yılmaz
Ömer Bayır
Mehmet Hakan Korkmaz
Ankara Yıldırım Beyazıt Üniversitesi, Türkiye
Emir Baki Denkbaş
Başkent Üniversitesi, Türkiye
Devamını Göster
Özet
Small interfering RNA (siRNA)-based gene silencing strategy has high potential on suppressing specific molecular targets, involved in cancer progression. However, the lack of an effective nanocarrier system that safely delivers siRNA to its target still limits the clinical applications of siRNA. This study aimed to develop albumin-sericin nanoparticles (Alb-Ser NPs) as a novel siRNA delivery system for laryngeal cancer treatment. Nanoparticle formulations composed of albumin and sericin at different ratios (1:1, 2:1, 1:2 ) were synthesized by desolvation method. The nanoparticles were modified with poly-L-lysine (PLL) for siRNA binding and decorated with hyaluronic acid (HA) to target laryngeal cancer cell line, Hep-2. HA/PLL/Alb-Ser NPs were individually loaded with siRNAs for casein kinase 2 (CK2), Absent, Small, or Homeotic-Like (ASH2L), and Cyclin D1 genes, which are overexpressed in Hep-2 cells. Downregulation of genes was confirmed by real-time PCR (RT-PCR). Size, morphological, and thermogravimetric characterizations revealed that Alb-Ser NPs having 2:1 () ratio are the most optimized formulation. Between 36.8 and 61.3% of siRNA entrapment efficiencies were achieved. HA/PLL-siRNA/Alb-Ser (2:1) NPs-mediated gene silencing resulted in a significant inhibition of cell growth and induction of apoptosis in cells. Our findings showed that HA/PLL/Alb-Ser (2:1) NPs were promising as a siRNA carrier.
Anahtar Kelimeler
Albumin | sericin | nanocarrier | siRNA | laryngeal cancer treatment
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Preparative Biochemistry and Biotechnology
Dergi ISSN 1082-6068 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 05-2019
Cilt No 49
Sayı 7
Sayfalar 1 / 12
Doi Numarası 10.1080/10826068.2019.1599395
Makale Linki https://www.tandfonline.com/doi/full/10.1080/10826068.2019.1599395